On Wednesday, October 4, 2017 ITPC Intellectual Property and Access to Medicines Lead Othoman Mellouk addressed the Human Rights Council’s 2017 Social Forum in Geneva, Switzerland, explaining why we can’t stand back while Big Pharma abuse the patent system at the expense of public health: Translating Principles into Action: Patents, Big Pharma and Access to […]
After 14 years of activism within the HIV treatment movement, ITPC Treatment Education Lead Bactrin Killingo is retiring. Official as of September 1, 2017, Bactrin’s leaving marks the end of an era for ITPC. He was in attendance at the International Treatment Preparedness Summit in Cape Town, South Africa in 2003, where ITPC was founded, […]
On 22-26 July 2017, ITPC Global, Regional Directors from ITPC LATCA and ITPC MENA, and representatives from ITPCru were in Paris, France for the 2017 International AIDS Society Conference on HIV Science (IAS 2017). With support from the Bridging the Gaps initiative, we were able to ensure treatment access issues – particularly as they affect key populations […]
Today, Monday, 24 July 2017, during the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), HIV treatment activists from around the world collectively blocked access to ViiV Healthcare’s promotional booth and stormed its presentation to physicians. The action, which included taping off ViiV’s booth, to deny access to conference delegates, highlights the […]
Why millions of people around the world are counting on India to protect them against harmful provision in the Regional Comprehensive Economic Partnership (RCEP) Trade Agreement PRESS RELEASE Hyderabad, 24 July 2017 – The Regional Comprehensive Economic Partnership (RCEP) is a free trade agreement that has been in negotiations since 2012, between 16 countries – […]
Last week, ITPC Latin America and the Carribean (ITPC LATCA) and allies began urging Guatemala and the international community to expand HIV treatment coverage through the use of compulsory licensing for the Lopinavir 200mg / Ritonavir 50 mg fixed-dose combination tablet. What is compulsory licensing? According to the Agreement on Trade-Related Aspects of Intellectual Property Rights […]
Join ITPC at IAS 2017 – Paris Join ITPC’s global team and regional directors at the International AIDS Society’s 9th Conference on HIV Science (IAS 2017) in Paris from 23 – 2016 July. We are co-hosting and participating in many sessions throughout the week. Check out our downloadable flyer (PDF) below for our full programme! […]
On 19 – 23 June, 2017, ARASA and ITPC hosted a 5-day community workshop on differentiated ART delivery in Bangkok, Thailand. With the support of the International AIDS Society (IAS), the workshop brought together more than 30 participants across 12 countries from seven networks of people living with HIV in Africa and Asia to strengthen […]
This past month, June 2017, ITPC and country partners gathered for three trainings as part of the Regional Community Treatment Observatory in West Africa (RCTO-WA), supported by the Global Fund. The three separate trainings – on governance, finance, and monitoring & evaluation – aimed to further build capacity among the RCTO-WA implementation teams in-country, and […]
On May 17-18, 2017, ITPC hosted a two-day event on PrEP that brought together more than 45 participants from 20 different countries representing civil society, key populations, governments, and technical expert groups.
Solange Baptiste, Executive Director of International Treatment Preparedness Coalition (ITPC), shares her reflections on the task ahead in her foreword for ITPC’s Annual Review 2016.
ITPC is outraged following a decision by the Indian Parliament to absolve itself from responsibility of providing treatment for people living with HIV in India.